Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Cryo-Cell InternationalFRA:ZCY +2.17%65 Days Inventory is 21.36 as of Feb. 2026, which is 38% below its 10-year median of 34.46. GuruFocus rates FRA:ZCY with a GF Score™ of 65/100 and a GF Value™ of €4.73 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 497 Healthcare Providers & Services companies, Cryo-Cell International ranks better than 50.5% on this metric.
The historical rank and industry rank for Cryo-Cell International's Days Inventory or its related term are showing as below:
FRA:ZCY'
s Days Inventory Range Over the Past 10 Years
Min: 18.35 Med: 34.46 Max: 42.66
Current: 29.29
During the past 13 years, Cryo-Cell International's highest Days Inventory was 42.66. The lowest was 18.35. And the median was 34.46.
FRA:ZCY's Days Inventory is ranked better than 50.5% of 497
companies
in the Healthcare Providers & Services industry
Industry Median: 29.67
vs FRA:ZCY: 29.29
Cryo-Cell International's Days Inventory
declined
from Feb. 2025 (31.64) to Feb. 2026 (21.36).
Inventory Turnover measures how fast the company turns over its inventory within a year.
Cryo-Cell International's Inventory Turnover for the
three
months ended in Feb. 2026 was 4.27.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Cryo-Cell International's Inventory-to-Revenue for the
three
months ended in Feb. 2026 was 0.05.
Cryo-Cell International (FRA:ZCY) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Cryo-Cell International's Inventory Turnover for the
three
months ended in Feb. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Cryo-Cell International's Inventory to Revenue for the
three
months ended in Feb. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Cryo-Cell International Days Inventory Related Terms
Cryo-Cell International Days Inventory Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:ZCY vs CCM, CDIX, EHSI: Days Inventory Comparison
For the Medical Care Facilities subindustry, Cryo-Cell International's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cryo-Cell International Days Inventory vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Cryo-Cell International's Days Inventory distribution charts can be found below:
* The bar in red indicates where Cryo-Cell International's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cryo-Cell International (FRA:ZCY) has a Days Inventory of 21.36 as of Feb. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Cryo-Cell International and its competitors. This is 38% below median its historical median of 34.46. Over the past decade, Cryo-Cell International's Days Inventory has ranged from 18.35 to 42.66. According to the industry distribution chart, Cryo-Cell International ranks #246 out of 497 companies in the Healthcare Providers & Services industry, placing it in the top 49.5%.
Is Cryo-Cell International's Days Inventory too high?
Cryo-Cell International's current Days Inventory of 21.36 is 38% below median its 10-year median of 34.46. Over the past 10 years, this metric has ranged from a low of 18.35 to a high of 42.66. The Healthcare Providers & Services industry median Days Inventory is 29.67. Cryo-Cell International's value of 21.36 is 28% below this industry median. Based on the distribution chart, Cryo-Cell International ranks #246 out of 497 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Cryo-Cell International has a GF Score™ of 65/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Cryo-Cell International's Days Inventory compare to CCM and CDIX?
According to the Healthcare Providers & Services industry distribution chart, Cryo-Cell International ranks #246 out of 497 companies for Days Inventory. This puts Cryo-Cell International in the upper half of its industry. The industry median Days Inventory is 29.67. Cryo-Cell International's value of 21.36 is 28% below this benchmark. Historically, Cryo-Cell International's own Days Inventory has ranged from 18.35 to 42.66 over the past decade. While the company's 10-year median is 34.46 vs. the industry median of 29.67, Cryo-Cell International has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Healthcare Providers & Services company?
The median Days Inventory among Healthcare Providers & Services companies is 29.67, based on 497 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Cryo-Cell International's current Days Inventory of 21.36 is 28% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Cryo-Cell International and its competitors. For the Healthcare Providers & Services industry, the median Days Inventory is 29.67 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cryo-Cell International's current Days Inventory is 21.36, which is 38% below median its own 10-year median of 34.46. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cryo-Cell International stock overvalued right now?
Based on GuruFocus' analysis, Cryo-Cell International (FRA:ZCY) is currently considered Possible Value Trap. The stock's GF Value™ is €4.73, compared to a current price of €2.82 — trading 40.4% below its estimated fair value. The current Days Inventory is 21.36, which is 38% below median its 10-year median of 34.46 and 28% below the Healthcare Providers & Services industry median of 29.67. Cryo-Cell International's overall GF Score™ is 65/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Cryo-Cell International (FRA:ZCY), the current Days Inventory is 21.36 as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Cryo-Cell International (FRA:ZCY) Overvalued in 2026?
Based on GuruFocus' analysis, Cryo-Cell International stock appears to be undervalued.
The current stock price of €2.82 is trading 40.4% below its estimated GF Value™ of €4.73.
GuruFocus considers Cryo-Cell International to be Possible Value Trap.
Key valuation signals for FRA:ZCY:
Days Inventory: 21.36 (38% below median its 10-year median of 34.46)
GF Value™: €4.73 vs. price of €2.82 (40.4% below fair value)
Industry Position: 28% below the Healthcare Providers & Services median (#246 of 497)
No single metric tells the full story. See the FRA:ZCY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.
65GF Score
Get the complete analysis for FRA:ZCY
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:ZCY has been successfully added to your 
